Numen
Numen is working on earlier cancer detection, with the stated goal of a future without cancer deaths.
Overview
Numen is a San Francisco company in the YC directory under diagnostics, machine learning and biotech, with the one-line mission of engineering a future without cancer deaths. Its public materials describe early-detection work but give little technical detail, so mechanism and evidence are not recorded here. The YC directory lists it at growth stage with a team of about 18. Included because cancer detection is its stated purpose; treat the record as thin until the company publishes more.
Funding
All startupsPages like this
not linked directly; found by shared links- CompanyDelee
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyAOA Dx
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyCambridge Cancer Genomics (CCG.ai)
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyBillionToOne
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyX-Zell
Shares Y Combinator, Liquid biopsy (ctDNA) and the tag yc.
- CompanyAluna
Shares Y Combinator and the tag yc.
- CompanyLiyfe
Shares Y Combinator and the tag yc.
- CompanyMednet (theMednet)
Shares Y Combinator and the tag yc.